259 related articles for article (PubMed ID: 10678176)
1. Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E.
Durbeej M; Cohn RD; Hrstka RF; Moore SA; Allamand V; Davidson BL; Williamson RA; Campbell KP
Mol Cell; 2000 Jan; 5(1):141-51. PubMed ID: 10678176
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy.
Durbeej M; Sawatzki SM; Barresi R; Schmainda KM; Allamand V; Michele DE; Campbell KP
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8910-5. PubMed ID: 12851463
[TBL] [Abstract][Full Text] [Related]
3. epsilon-sarcoglycan replaces alpha-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex.
Straub V; Ettinger AJ; Durbeej M; Venzke DP; Cutshall S; Sanes JR; Campbell KP
J Biol Chem; 1999 Sep; 274(39):27989-96. PubMed ID: 10488149
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy.
Coral-Vazquez R; Cohn RD; Moore SA; Hill JA; Weiss RM; Davisson RL; Straub V; Barresi R; Bansal D; Hrstka RF; Williamson R; Campbell KP
Cell; 1999 Aug; 98(4):465-74. PubMed ID: 10481911
[TBL] [Abstract][Full Text] [Related]
5. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex.
Hack AA; Lam MY; Cordier L; Shoturma DI; Ly CT; Hadhazy MA; Hadhazy MR; Sweeney HL; McNally EM
J Cell Sci; 2000 Jul; 113 ( Pt 14)():2535-44. PubMed ID: 10862711
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of muscle degeneration in the delta-sarcoglycan-deficient hamster.
Straub V; Duclos F; Venzke DP; Lee JC; Cutshall S; Leveille CJ; Campbell KP
Am J Pathol; 1998 Nov; 153(5):1623-30. PubMed ID: 9811355
[TBL] [Abstract][Full Text] [Related]
7. Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice.
Duclos F; Straub V; Moore SA; Venzke DP; Hrstka RF; Crosbie RH; Durbeej M; Lebakken CS; Ettinger AJ; van der Meulen J; Holt KH; Lim LE; Sanes JR; Davidson BL; Faulkner JA; Williamson R; Campbell KP
J Cell Biol; 1998 Sep; 142(6):1461-71. PubMed ID: 9744877
[TBL] [Abstract][Full Text] [Related]
8. Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice.
Araishi K; Sasaoka T; Imamura M; Noguchi S; Hama H; Wakabayashi E; Yoshida M; Hori T; Ozawa E
Hum Mol Genet; 1999 Sep; 8(9):1589-98. PubMed ID: 10441321
[TBL] [Abstract][Full Text] [Related]
9. Expression of gamma -sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex.
Barresi R; Moore SA; Stolle CA; Mendell JR; Campbell KP
J Biol Chem; 2000 Dec; 275(49):38554-60. PubMed ID: 10993904
[TBL] [Abstract][Full Text] [Related]
10. Sarcoglycans in vascular smooth and striated muscle.
Wheeler MT; McNally EM
Trends Cardiovasc Med; 2003 Aug; 13(6):238-43. PubMed ID: 12922020
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of gamma-sarcoglycan induces severe muscular dystrophy. Implications for the regulation of Sarcoglycan assembly.
Zhu X; Hadhazy M; Groh ME; Wheeler MT; Wollmann R; McNally EM
J Biol Chem; 2001 Jun; 276(24):21785-90. PubMed ID: 11287429
[TBL] [Abstract][Full Text] [Related]
12. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations.
Barresi R; Di Blasi C; Negri T; Brugnoni R; Vitali A; Felisari G; Salandi A; Daniel S; Cornelio F; Morandi L; Mora M
J Med Genet; 2000 Feb; 37(2):102-7. PubMed ID: 10662809
[TBL] [Abstract][Full Text] [Related]
13. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
Crosbie RH; Barresi R; Campbell KP
FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
[TBL] [Abstract][Full Text] [Related]
14. Sarcoglycans in muscular dystrophy.
Hack AA; Groh ME; McNally EM
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
[TBL] [Abstract][Full Text] [Related]
15. Pathological analysis of muscle hypertrophy and degeneration in muscular dystrophy in gamma-sarcoglycan-deficient mice.
Sasaoka T; Imamura M; Araishi K; Noguchi S; Mizuno Y; Takagoshi N; Hama H; Wakabayashi-Takai E; Yoshimoto-Matsuda Y; Nonaka I; Kaneko K; Yoshida M; Ozawa E
Neuromuscul Disord; 2003 Mar; 13(3):193-206. PubMed ID: 12609501
[TBL] [Abstract][Full Text] [Related]
16. Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice.
Porter JD; Merriam AP; Hack AA; Andrade FH; McNally EM
Neuromuscul Disord; 2001 Mar; 11(2):197-207. PubMed ID: 11257478
[TBL] [Abstract][Full Text] [Related]
17. Muscle degeneration without mechanical injury in sarcoglycan deficiency.
Hack AA; Cordier L; Shoturma DI; Lam MY; Sweeney HL; McNally EM
Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10723-8. PubMed ID: 10485893
[TBL] [Abstract][Full Text] [Related]
18. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex.
Crosbie RH; Lebakken CS; Holt KH; Venzke DP; Straub V; Lee JC; Grady RM; Chamberlain JS; Sanes JR; Campbell KP
J Cell Biol; 1999 Apr; 145(1):153-65. PubMed ID: 10189375
[TBL] [Abstract][Full Text] [Related]
19. Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E).
Bönnemann CG; Passos-Bueno MR; McNally EM; Vainzof M; de Sá Moreira E; Marie SK; Pavanello RC; Noguchi S; Ozawa E; Zatz M; Kunkel LM
Hum Mol Genet; 1996 Dec; 5(12):1953-61. PubMed ID: 8968749
[TBL] [Abstract][Full Text] [Related]
20. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse.
Gibertini S; Zanotti S; Savadori P; Curcio M; Saredi S; Salerno F; Andreetta F; Bernasconi P; Mantegazza R; Mora M
Cell Tissue Res; 2014 May; 356(2):427-43. PubMed ID: 24723230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
